Gagnon Advisors, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001599466

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 24 positions · Total reported value $182.06M · Top-10 concentration 63.2% · Updated 2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

Turnover: 28.0% · 3 new · 3 cut · 1 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +24.8% · vs SPY +22.7% · Prev Value $151.14M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +12.2% · vs SPY +10.1% · Latest Value $182.06M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Gagnon Advisors, LLC disclosed 24 equity positions with a combined reported value of $182.06M. The filing implies a focused portfolio: its ten largest positions account for 63.2% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were CDNA ($18.65M), EPD ($12.10M), WGS ($11.79M). By sector, the heaviest allocations are Health Care 41.7%, Technology 33.7%. Versus the prior quarter, allocation shifted toward Technology (+4.8pp), Consumer Staples (+2.0pp) and away from Consumer Discretionary (-1.4pp), Real Estate (-1.4pp).

Versus the prior quarter, Gagnon Advisors, LLC opened 3 new positions, trimmed 3 and fully exited 1, a turnover rate of 28.0% of positions. The portfolio's overlap with the prior quarter was 84% of names.

The largest new positions opened in Q3 2026 were NVGS ($7.61M), BKD ($3.99M), BV ($3.87M).

Of the 1 positions fully exited versus the prior quarter, the largest were HZO ($3.56M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • NVGS NAVIGATOR HLDGS LTD · $7.61M
  • BKD BROOKDALE SR LIVING INC · $3.99M
  • BV BRIGHTVIEW HLDGS INC · $3.87M

Fully Exited (vs previous quarter)

  • HZO MARINEMAX INC · prev qtr: $3.56M

Insider Transactions (Form 4)

Latest Gagnon Advisors, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Gagnon Advisors, LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 22 US equity positions with a combined value of $151.14M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79567 (status: Approved), registered 2014-04-16
  • Regulatory AUM (Form ADV): $187.31M as of 2026-08-12
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 4 hedge funds

Portfolio Structure

  • 22 positions · $151.14M reported value (Q2 2026)
  • Top 10 holdings = 69.9% of reported value
  • Largest position: CDNA (CAREDX INC) at 10.3%
  • Average position size: $6.87M

Sector Tilt

  • Health Care 44.1%
  • Information Technology 28.9%
  • Consumer Discretionary 11.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 3 new, 5 added, 3 exited
  • 14 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund reduced positions in two Health Care stocks (CDNA, WGS) while holding others, suggesting a cautious stance on biotech/healthcare, possibly due to price volatility or sector-specific concerns. No new additions were made to the top 10, indicating a defensive or selective approach. 2. Key moves: - Reduced: CDNA (CAREDX INC, Health Care) by 47.5% shares (-$1.07M value impact), WGS (GENEDX HOLDINGS CORP, Health Care) by 8.3% shares (-$0.15M value impact). - Held: All other top-10 positions, with no new additions in the top 10 (though 3 new positions exist outside the top 10). 3. Portfolio structure: Active management with a tilt toward Technology (FIVN, HNGE, FRSH) and Utilities (EPD), reduced Health Care exposure. Moderate risk appetite, with stable positions in real estate (EQIX) and consumer discretionary (AMRC). 4. Per-holding one-liner: - CDNA: CAREDX INC (biotech, unverified if ETF). - EPD: Enterprise Products Partners (midstream energy). - WGS: Genedx Holdings (genetic testing, unverified). - FIVN: Five9 (cloud contact software). - HNGE: Hinge Health (digital musculoskeletal care). - EQIX: Equinix (data center REIT). - BLFS: Biolife Solutions (blood storage, unverified). - FRSH: Freshworks (cloud-based software). - AMRC: Ameresco (energy efficiency, unverified). - PCRX: Pacira Biosciences (pain management, unverified). 5. Style summary: Cautious biotech trimming with stable tech/utility holdings, signaling selective risk-taking amid sector volatility.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-15 04:10

Sector Allocation

Health Care 41.7%
Technology 33.7%
Utilities 6.6%
Financials 0.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 286.89K $18.65M 10.24%
10.24%
Reduce
2 339.88K $12.10M 6.65%
6.65%
Hold
3 163.02K $11.79M 6.47%
6.47%
Reduce
4 336.28K $11.44M 6.28%
6.28%
Hold
5 113.30K $11.02M 6.05%
6.05%
Hold
6 10.71K $10.84M 5.95%
5.95%
Hold
7 274.22K $10.65M 5.85%
5.85%
Hold
8 776.21K $9.93M 5.45%
5.45%
Hold
9 472.80K $9.79M 5.38%
5.38%
Hold
10 352.64K $8.83M 4.85%
4.85%
Hold
11 634.99K $8.79M 4.83%
4.83%
Hold
12 328.49K $7.61M 4.18%
4.18%
New
13 257.92K $6.84M 3.76%
3.76%
Add
14 1.53M $6.81M 3.74%
3.74%
Hold
15 438.04K $5.91M 3.25%
3.25%
Hold
16 962.19K $5.58M 3.06%
3.06%
Hold
17 1.29M $5.04M 2.77%
2.77%
Add
18 432.19K $4.56M 2.50%
2.50%
Add
19 361.62K $4.26M 2.34%
2.34%
Hold
20 368.35K $3.99M 2.19%
2.19%
New
21 386.51K $3.87M 2.12%
2.12%
New
22 2.49M $3.18M 1.75%
1.75%
Add
23 242.04K $471.98K 0.26%
0.26%
Add
24 12.96K $107.07K 0.06%
0.06%
Reduce

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 100% R 100% F1 100% (modelled on 2026-Q2; 10/10 hit)

Historical Backtest (11 quarters)

Avg precision 81% · recall 81% · F1 81% · avg rank error 2.3 · Top-10 turnover 20%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 80% 80% 80% AL · NVGS · EPD · FIVN · BL · CDNA · AMRC · PROF · FRSH · SCWX AL · EPD · NVGS · BL · FIVN · CDNA · PROF · FRSH · EQIX · BLFS
2024-Q2 60% 60% 60% EPD · AL · NVGS · BL · FIVN · CDNA · PROF · FRSH · EQIX · SCWX EPD · CDNA · AL · NVGS · AOSL · WGS · PROF · BLFS · AMRC · FIVN
2024-Q3 80% 80% 80% EPD · CDNA · AL · NVGS · WGS · AOSL · PROF · BLFS · FIVN · AMRC PSIX · CDNA · WGS · EPD · AL · NVGS · AMRC · BLFS · SCWX · PROF
2024-Q4 80% 80% 80% PSIX · CDNA · WGS · EPD · AL · NVGS · AMRC · BLFS · SCWX · PROF WGS · PSIX · EPD · AL · CDNA · NVGS · FRSH · BLFS · FIVN · PROF
2025-Q1 80% 80% 80% WGS · PSIX · EPD · AL · CDNA · NVGS · FRSH · BLFS · FIVN · PROF EPD · WGS · AL · PSIX · CDNA · NVGS · FRSH · EQIX · BL · BLFS
2025-Q2 100% 100% 100% EPD · WGS · AL · PSIX · CDNA · NVGS · FRSH · EQIX · AMRC · BL WGS · PSIX · AL · EPD · CDNA · EQIX · BL · NVGS · AMRC · FRSH
2025-Q3 80% 80% 80% AL · WGS · PSIX · EPD · EQIX · CDNA · AMRC · BL · NVGS · FRSH AMRC · WGS · FRSH · AL · EPD · EQIX · NVGS · CDNA · DV · BLFS
2025-Q4 80% 80% 80% AMRC · FRSH · WGS · AL · EPD · EQIX · DV · NVGS · CDNA · TMCI WGS · AMRC · AL · EPD · CDNA · NVGS · EQIX · PROF · BL · FRSH
2026-Q1 80% 80% 80% WGS · AMRC · AL · EPD · CDNA · NVGS · EQIX · PROF · FRSH · FIVN EPD · AMRC · EQIX · NVGS · SGOV · WGS · CDNA · PCRX · PROF · FRSH
2026-Q2 70% 70% 70% EPD · AMRC · EQIX · NVGS · SGOV · WGS · CDNA · PCRX · PROF · FRSH CDNA · AMRC · EPD · WGS · EQIX · HNGE · PCRX · FRSH · BLFS · FIVN
2026-Q3 ★ 100% 100% 100% CDNA · AMRC · WGS · EPD · EQIX · HNGE · PCRX · FRSH · BLFS · FIVN CDNA · EPD · WGS · FIVN · HNGE · EQIX · BLFS · FRSH · AMRC · PCRX

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-12. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-12 Trading days31 Holdings4 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-12, and will update as prices arrive.

Portfolio return-4.17%Buy & hold
QQQ synthetic benchmark-11.15%Liquidity weighted
Excess return+6.98%vs benchmark
Barra annualised vol39.7%Model estimate
Realised vol36.5%Annualised in window
Weighted beta0.88Raw exposure
Factor / specific risk45% / 55%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)78.285.592.7100.0107.310-0110-2211-12Gagnon Advisors, LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-4.17%Disclosed long book
QQQ synthetic benchmark-11.15%Liquidity-weighted constituents
Model universe, equal weight+2.04%Opportunity-cost reference
Excess return+6.98%Portfolio − benchmark
Arithmetic return sum-3.45%Difference vs compounded is the cross term
Weighted raw beta0.88Weighted holding betas
Realised volatility (annualised)36.50%Daily returns in window
Barra model volatility (annualised)39.71%Factor + specific
Factor share of variance44.7%Barra factors
Specific share of variance55.3%Stock residuals
Reported value$40.1M13F long US equity

2. Return attribution

The -3.45% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +0.84% 24.2%
Momentum & Growth 3 +1.87% 54.2%
Volatility & Tail Risk 7 -3.22% -93.3%
Industry 12 +6.73% 194.8%
Specific 1 -9.67% -280.0%
Return attribution (style + industry, %)-5.7-2.9+0.0+2.9+5.7Information Technology-0.36Amihud Illiquidity+0.53Skewness-0.68Momentum+0.76Growth+0.80Turnover+0.87Max Drawdown+1.07Real Estate+1.79Residual Volatility+2.40Size+2.61Kurtosis-2.92Mid Cap-3.26Historical Volatility-3.37Health Care+5.29
Factor Type Exposure Factor return Contribution Share of |return|
Health Care Industry +0.56 +9.47% +5.29% 153.3%
Size Style -1.35 -1.93% +2.61% 75.5%
Residual Volatility Style +1.12 +2.15% +2.40% 69.6%
Real Estate Industry +0.27 +6.64% +1.79% 51.9%
Max Drawdown Style -1.05 -1.01% +1.07% 30.9%
Turnover Style -0.20 -4.35% +0.87% 25.2%
Growth Style +0.54 +1.50% +0.80% 23.3%
Momentum Style -0.23 -3.32% +0.76% 22.0%
Amihud Illiquidity Style +1.76 +0.30% +0.53% 15.3%
Short-term Reversal Style +0.28 +1.12% +0.31% 8.9%
Leverage (Downside Vol) Style -0.06 -3.05% +0.19% 5.4%
Non-linear Size Style +2.21 +0.07% +0.15% 4.4%
Beta Style +0.02 +4.92% +0.09% 2.6%
Liquidity Style +0.30 -0.20% -0.06% -1.8%
Information Technology Industry +0.17 -2.11% -0.36% -10.4%
Skewness Style +0.14 -4.77% -0.68% -19.7%
Kurtosis Style -0.47 +6.17% -2.92% -84.5%
Mid Cap Style +1.70 -1.92% -3.26% -94.4%
Historical Volatility Style +0.34 -9.82% -3.37% -97.5%
Specific Specific — — -9.67% -280.0%

3. Risk attribution

Annualised volatility is 39.71%; factor risk explains 44.7% of variance and specific risk 55.3%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-59.7-29.9+0.0+29.9+59.7Residual Volatility-0.72Short-term Reversal+0.32Amihud Illiquidity+0.80Kurtosis+1.39Growth+1.51Information Technology+2.08Historical Volatility+2.55Real Estate+4.31Size+5.18Max Drawdown+5.21Non-linear Size+5.84Health Care+7.35Mid Cap+9.19Specific+55.30
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 55.3% +21.96% 22.0%
Mid Cap Style +1.70 9.2% +3.65% 3.6%
Health Care Industry +0.56 7.3% +2.92% 2.9%
Non-linear Size Style +2.21 5.8% +2.32% 2.3%
Max Drawdown Style -1.05 5.2% +2.07% 2.1%
Size Style -1.35 5.2% +2.06% 2.1%
Real Estate Industry +0.27 4.3% +1.71% 1.7%
Historical Volatility Style +0.34 2.5% +1.01% 1.0%
Information Technology Industry +0.17 2.1% +0.83% 0.8%
Growth Style +0.54 1.5% +0.60% 0.6%
Kurtosis Style -0.47 1.4% +0.55% 0.6%
Amihud Illiquidity Style +1.76 0.8% +0.32% 0.3%
Short-term Reversal Style +0.28 0.3% +0.13% 0.1%
Liquidity Style +0.30 -0.2% -0.09% -0.1%
Residual Volatility Style +1.12 -0.7% -0.29% -0.3%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.7-0.60.41.52.6Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -1.35 +2.10 -3.45
Non-linear Size +2.21 +1.68 +0.54
Mid Cap +1.70 +0.13 +1.57
Beta +0.02 +1.29 -1.28
Momentum -0.23 +0.72 -0.95
Short-term Reversal +0.28 -0.64 +0.92
Residual Volatility +1.12 -0.40 +1.52
Historical Volatility +0.34 +0.86 -0.52
Liquidity +0.30 +0.11 +0.18
Amihud Illiquidity +1.76 +1.16 +0.60
Turnover -0.20 +0.21 -0.41
Growth +0.54 +0.58 -0.05
Leverage (Downside Vol) -0.06 +0.14 -0.20
Skewness +0.14 +0.24 -0.10
Kurtosis -0.47 +0.21 -0.69
Max Drawdown -1.05 -0.08 -0.97

5. Industry allocation & Brinson

Industry allocation (weight, %)-7.414.736.858.981.0Communication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsInformation TechnologyReal EstateHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 17.1% 73.6% +3.35% -16.67% +3.55% +14.74% -11.33% +12.85%
Real Estate 27.0% 0.0% +5.58% +0.00% +2.81% +0.00% +1.51% +1.51%
Communication Services 0.0% 2.6% +0.00% -12.15% +0.05% +0.32% -0.32% +0.32%
Utilities 0.0% 0.8% +0.00% +10.14% -0.16% -0.08% +0.08% -0.08%
Consumer Staples 0.0% 0.8% +0.00% +15.33% -0.22% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +5.93% -1.44% -0.52% +0.52% -0.52%
Industrials 0.0% 11.1% +0.00% +7.87% -2.03% -0.87% +0.87% -0.87%
Health Care 55.9% 1.7% -12.77% +9.50% +10.79% -0.38% -12.07% -7.31%
Total +13.25% +13.03% -20.57% +5.72%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
WGS GENEDX HOLDINGS CORP Health Care 29.38% -23.76% -6.98% Reduce
EQIX EQUINIX INC Real Estate 27.02% +5.58% +1.51% Hold
BLFS BIOLIFE SOLUTIONS INC Health Care 26.55% -0.62% -0.16% Hold
BL BLACKLINE INC Information Technology 17.05% +3.36% +0.57% Add
Contribution rank Symbol Sector Weight Return Contribution
1 EQIX Real Estate 27.02% +5.58% +1.51%
2 BL Information Technology 17.05% +3.36% +0.57%
3 BLFS Health Care 26.55% -0.62% -0.16%
4 WGS Health Care 29.38% -23.76% -6.98%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-12 (31 trading days), the reported portfolio returned -4.17%, versus -11.15% for the QQQ synthetic benchmark — an excess of +6.98%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +5.29%, Size +2.61%, Residual Volatility +2.40%; the largest drags came from Historical Volatility -3.37%, Mid Cap -3.26%, Kurtosis -2.92%. Specific (stock-level) return contributed -9.67%.
  3. Risk attribution: Barra model volatility is 39.71% annualised; factor risk explains 45% of variance and specific risk 55%. The largest factor risk sources are Mid Cap 9.2%, Health Care 7.3%, Non-linear Size 5.8%.
  4. Style tilt: size -1.35, momentum -0.23, volatility +0.34, liquidity +0.30; the weighted raw beta is 0.88. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+54.2 pp), the largest underweight is Information Technology (-56.6 pp). Allocation contributed +13.25%, selection +13.03% and interaction -20.57%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Gagnon Advisors, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Gagnon Advisors, LLC reported 24 equity positions worth $182.06M in aggregate; its largest disclosed positions were CDNA ($18.65M), EPD ($12.10M), WGS ($11.79M).

How large is Gagnon Advisors, LLC's portfolio?

Gagnon Advisors, LLC reported $182.06M of long equity holdings across 24 positions as of 2026-Q3. Top-10 holdings account for 63.2% of reported value.

What is Gagnon Advisors, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/gagnon-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →